NX1NEXALIS THERAPEUTICS LTDMarket sensitive

First eligible participant screened - phase 1 IRX-616a study

Date and time
Announcement type
Company Update

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case